Novo Nordisk A/S - Summary of Law Enforcement Action
Novo entered into a three-year deferred prosecution agreement with the Department of Justice, whereby it agreed to pay a $9 million penalty.
To read more
Subscribe to Global Investigations Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Investigations Review experts.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10